Home  >  News

Filter your search

Clear All Filters

Newsletter Signup Filter Facebook Like Us Absave Sale Labsave Absave Filter

News

Abcam Introduces Exclusive Range of Highly Validated Antibody Conjugates
Abcam Introduces Exclusive Range of Highly Validated Antibody Conjugates
Abcam
03/09/2014

Cambridge, UK, September 3, 2014: Abcam plc, a leading provider of protein research tools and services, announced today it has launched an exclusive range of highly validated conjugated antibodies for use in key imaging applications including immunofluorescence, flow cytometry, and fluorescent western blotting.Abcam’s conjugated antibodies enable scientists to easily perform multi-protein analysis. It is essential for scientists to study and image proteins in their...
Abcam Introduces Alexa Fluor® 680/790 Secondary Antibodies for Fluorescent Western Blotting
Abcam Introduces Alexa Fluor® 680/790 Secondary Antibodies for Fluorescent Western Blotting
Abcam
04/03/2014

New range offers high performance antibodies for more efficient western blottingCambridge, UK, March 03 2014: Abcam plc, a global leader in the supply of innovative protein research tools, announced today it has added Alexa Fluor® 680/790 secondary antibodies for fluorescent western blotting to its existing Alexa Fluor conjugated antibody range. Produced and extensively validated in Abcam laboratories, the F:P ratios of  Alexa Fluor 680/790 have been optimised to...
Abcam Announces Winner of 15 Discoveries Contest
Abcam Announces Winner of 15 Discoveries Contest
Abcam
03/02/2014

Contest celebrates scientific breakthroughs with $15,000 research grantCambridge UK, February 3, 2014: Abcam plc, a global leader in the supply of innovative protein research tools, today announced Yali Huang as the winner of its 15 discoveries contest. Ms. Huang conducts her work at the Early Embryo Development lab at the MRC Centre of Regenerative Medicine, University of Edinburgh, Scotland. The contest recognises the most innovative and exciting scientific breakthroughs...
Abcam Named AIM Company of the Year
Abcam Named AIM Company of the Year
Abcam
14/10/2013

Award celebrates achievements of a dynamic business with strong future growth prospectsCambridge UK, October 14, 2013: Abcam Plc., a leading provider of life science research tools, announced today it has been named ‘Company of the Year’ in the 2013 AIM Awards. The AIM awards celebrate outstanding achievement of quoted companies and entrepreneurs who have harnessed AIM to help them fulfil their ambition and growth potential in the last twelve months.Company of...
Abcam Launches SimpleStep ELISA Kits
Abcam Launches SimpleStep ELISA Kits
Abcam
09/09/2013

Kits offer enhanced performance and ease of use to accelerate immunoassay researchCambridge, UK, September 09 2013: Abcam plc., a producer and distributor of high quality protein research tools, announced today that it has launched a range of SimpleStep™ ELISA kits. The new kits have a greatly simplified protocol when compared to standard multi-step ELISAs, providing significant time savings and ease of use. Offering enhanced performance, SimpleStep ELISA kits are...
Abcam Licenses Novel Technology from Columbia University for Neurobiological Research
Abcam Licenses Novel Technology from Columbia University for Neurobiological Research
Abcam
08/04/2013

New products from Abcam Biochemicals will support research into neurodegeneration and drug addictionBristol and Cambridge, UK, April 08, 2013: Abcam Plc., a producer and distributor of high quality protein research tools, and Columbia University, announced today that they have entered into an exclusive license agreement for two novel pH-responsive fluorescent false neurotransmitters (FFNs). FFNs are probes which act as optical tracers, allowing imaging of neurotransmitter...